AI Science Tracker

Machine-learning screening selects compounds active against Candida

Federal University of Goiás · 2 Jul 2025 · biology

Discovery

Machine-learning screening selects compounds active against Candida

Random-forest prediction and chemical filters helped narrow commercial compounds for experimental testing. Of 17 selected compounds, the paper reports 11 with inhibitory activity against Candida albicans at tested concentrations. Compound 17 had an IC50 of 0.071 μM and MIC of 4.5 μM, compared with fluconazole values of 0.39 μM and 0.78 μM, respectively; its lower IC50 but higher MIC does not establish superiority. The reported selectivity-index definition appears inconsistent with tabulated values, so this draft omits that index. Cell assays do not establish clinical efficacy or safety.

Technology: Random-forest classifiers and regressors; chemical similarity filtering

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Peer-reviewed paper
  • Test type: direct test
  • Tested: Primary full text reports 17 experimentally tested compounds and 11 active; compound-specific IC50/MIC values are stated with different fluconazole comparators.
  • Still unknown: Molecule-level previous activity, exact compound identities and independent replication remain to review.
  • AI role: Random-forest models predict activity and toxicity to prioritize commercially available compounds; selected compounds are experimentally tested.

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12320878/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 16 Nov 2026. Review scope: Primary full-text article on PMC indexed text and methods/results read; online date, title and DOI verified..

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open in the full catalog for filters, charts and related discoveries.